, Volume 60, Issue 12, pp 2532–2533 | Cite as

Europe has to step up its efforts to produce innovative and safe diabetes technology

  • Miriam Cnop
  • Tomasz Klupa
  • Nikolaos Tentolouris
  • Anna Novials
  • Rémy Burcelin
  • Mischa van Eimeren


Artificial pancreas Closed loop European Database on Medical Devices European parliament Glucose meter Innovation Insulin pump Legislation Medical device Safety 



European Union


European Database on Medical Devices


International Diabetes Federation



Work in the authors’ laboratories is supported by the European Union’s Horizon 2020 research and innovation programme, project T2DSystems, under grant agreement no. 667191, and the Innovative Medicines Initiative 2 Joint Undertaking, project INNODIA, under grant agreement no. 115797, which receives support from the European Union’s Horizon 2020 research and innovation programme, EFPIA, JDRF and the Leona M. and Harry B. Helmsley Charitable Trust.

Duality of interest

The authors declare that there is no duality of interest associated with this manuscript.

Contribution statement

MC and MvE wrote the paper. TK, NT, AN and RB revised it. All authors approved the final version.


  1. 1.
    Thabit H, Hovorka R (2016) Continuous subcutaneous insulin infusion therapy and multiple daily insulin injections in type 1 diabetes mellitus: a comparative overview and future horizons. Expert Opin Drug Deliv 13:389–400CrossRefPubMedGoogle Scholar
  2. 2.
    Guilhem I, Balkau B, Lecordier F et al (2009) Insulin pump failures are still frequent: a prospective study over 6 years from 2001 to 2007. Diabetologia 52:2662–2664CrossRefPubMedGoogle Scholar
  3. 3.
    Guenego A, Bouzille G, Breitel S et al (2016) Insulin pump failures: has there been an improvement? Update of a prospective observational study. Diabetes Technol Ther 18:820–824CrossRefPubMedGoogle Scholar
  4. 4.
    Wikipedia (2017). Poly Implant Prothèse. Available from Accessed 17 Aug 2017
  5. 5.
    Heinemann L, Fleming GA, Petrie JR, Holl RW, Bergenstal RM, Peters AL (2015) Insulin pump risks and benefits: a clinical appraisal of pump safety standards, adverse event reporting and research needs. A joint statement of the European Association for the Study of Diabetes and the American Diabetes Association Diabetes Technology Working Group. Diabetologia 58:862–870CrossRefPubMedGoogle Scholar
  6. 6.
    European Commission (2017). Medical devices regulatory framework. Available from Accessed 17 Aug 2017
  7. 7.
    European Association for the Study of Diabetes (2017). Diabetes technology meeting report. Available from Accessed 17 Aug 2017

Copyright information

© Springer-Verlag GmbH Germany 2017

Authors and Affiliations

  • Miriam Cnop
    • 1
    • 2
    • 3
  • Tomasz Klupa
    • 3
    • 4
  • Nikolaos Tentolouris
    • 3
    • 5
  • Anna Novials
    • 3
    • 6
    • 7
  • Rémy Burcelin
    • 3
    • 8
  • Mischa van Eimeren
    • 9
  1. 1.ULB Center for Diabetes ResearchUniversité Libre de BruxellesBrusselsBelgium
  2. 2.Division of EndocrinologyErasmus HospitalBrusselsBelgium
  3. 3.EASD-EU Committee, EASDDüsseldorfGermany
  4. 4.Department of Metabolic DiseasesJagiellonian University Medical CollegeKrakówPoland
  5. 5.First Department of Internal MedicineNational and Kapodistrian University of AthensAthensGreece
  6. 6.Diabetes and Obesity Research Laboratory, Institut D’Investigacions Biomèdiques (IDIBAPS)Hospital Clinic de BarcelonaBarcelonaSpain
  7. 7.Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Spain
  8. 8.Institut des Maladies Métaboliques et Cardiovasculaires (I2MC), Inserm 1048ToulouseFrance
  9. 9.EASD HeadquartersDüsseldorfGermany

Personalised recommendations